Histopathological Clues of Enhanced Inflammation in the Placental Tissue of Women with Chronic Venous Disease in Lower Limbs during Pregnancy
María Asunción Sánchez-Gil,Oscar Fraile-Martinez,Cielo García-Montero,María Del Val Toledo,Luis G. Guijarro,Juan A. De León-Luis,Coral Bravo,Raúl Díaz-Pedrero,Laura López-Gonzalez,Miguel A. Saez,Melchor Álvarez-Mon,Natalio García-Honduvilla,Miguel A. Ortega
DOI: https://doi.org/10.3390/jpm14010087
IF: 3.5083
2024-01-13
Journal of Personalized Medicine
Abstract:It is estimated that approximately one in three women develop chronic venous disease (CVD) during pregnancy, a broad spectrum of morphofunctional disorders affecting the venous system in different regions of the body, including the lower limbs. A growing body of evidence supports the diverse maternofetal consequences derived from this condition, with the placenta being an organ particularly affected. Among other consequences, having CVD during pregnancy has been associated with systemic inflammation and altered cytokines and chemokine profiles in the maternal and fetal serum related to this condition. In the present work, we aimed to analyze if these inflammatory changes also occurred in the placental tissue of women with CVD, exploring by immunohistochemistry and real-time PCR (RT-qPCR) gene and protein expression of critical inflammatory markers like allograft inflammatory factor 1 (AIF-1), interleukin 10 (IL-10), IL-12A, and IL-18. Our results demonstrate an enhanced tissue expression of AIF-1, IL-12A, and IL-18, accompanied by a decrease in IL-10 in the placentas of women who had undergone CVD during pregnancy. Overall, our results suggest a possible pathophysiological role of inflammation in the placental tissue of women with CVD during pregnancy, although the precise consequences of this feature remain to be deeply analyzed.
medicine, general & internal,health care sciences & services